Citation: Jg. Moller et al., CAPILLARY-ELECTROPHORESIS WITH LASER-INDUCED FLUORESCENCE - A ROUTINEMETHOD TO DETERMINE MOXIFLOXACIN IN HUMAN-BODY FLUIDS IN VERY SMALL SAMPLE VOLUMES, Journal of chromatography B. Biomedical sciences and applications, 716(1-2), 1998, pp. 325-334
Citation: H. Stass et al., PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF ASCENDING SINGLE DOSES OF MOXIFLOXACIN, A NEW 8-METHOXY QUINOLONE, ADMINISTERED TO HEALTHY-SUBJECTS, Antimicrobial agents and chemotherapy, 42(8), 1998, pp. 2060-2065
Citation: H. Peltola et al., SINGLE-DOSE AND STEADY-STATE PHARMACOKINETICS OF A NEW ORAL SUSPENSION OF CIPROFLOXACIN IN CHILDREN, Pediatrics, 101(4), 1998, pp. 658-662
Authors:
HERPERTZ S
GRETZER A
MUHLBAUER V
STEINMEYER EM
STASS H
Citation: S. Herpertz et al., EXPERIMENTAL PROOF OF AFFECT DYSREGULATIO N IN PATIENTS WITH SELF-DESTRUCTIVE BEHAVIOR, Nervenarzt, 69(5), 1998, pp. 410-418
Citation: Jg. Moller et al., CAPILLARY ELECTROPHORESIS (CE) WITH LASER-INDUCED FLUORESCENCE (LIF) DETECTION - A POWERFUL BIOANALYTICAL TOOL FOR KINETIC-STUDIES OF QUINOLONES, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 676-676
Authors:
STASS H
BOSCHE P
DELESEN H
KUBITZA D
MAHLER HF
Citation: H. Stass et al., BIOPHARMACEUTICAL QUALITY ASSURANCE OF MOXIFLOXACIN TABLET DEVELOPMENT, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 685-685
Citation: Kh. Bannefeld et al., CAPILLARY ELECTROPHORESIS WITH LASER-INDUCED FLUORESCENCE DETECTION, AN ADEQUATE ALTERNATIVE TO HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, FORTHE DETERMINATION OF CIPROFLOXACIN AND ITS METABOLITE DESETHYLENECIPROFLOXACIN IN HUMAN PLASMA, Journal of chromatography B. Biomedical sciences and applications, 692(2), 1997, pp. 453-459
Citation: H. Stass et A. Dalhoff, DETERMINATION OF BAY-12-8039, A NEW 8-METHOXYQUINOLONE, IN HUMAN-BODYFLUIDS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION USING ON-COLUMN FOCUSING, Journal of chromatography B. Biomedical sciences and applications, 702(1-2), 1997, pp. 163-174
Authors:
BREITHAUPTGROGLER K
MALERCZYK C
BELZ GG
BUTZER R
HERRMANN V
STASS H
WENSING G
Citation: K. Breithauptgrogler et al., PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES OF AN ANGIOTENSIN-II RECEPTOR ANTAGONIST - CHARACTERIZATION BY USE OF SCHILD REGRESSION TECHNIQUE IN MAN, International journal of clinical pharmacology and therapeutics, 35(10), 1997, pp. 434-441
Authors:
SCHAEFER HG
STASS H
WEDGWOOD J
HAMPEL B
FISCHER C
KUHLMANN J
SCHAAD UB
Citation: Hg. Schaefer et al., PHARMACOKINETICS OF CIPROFLOXACIN IN PEDIATRIC CYSTIC-FIBROSIS PATIENTS, Antimicrobial agents and chemotherapy, 40(1), 1996, pp. 29-34